BIOCHEMICAL AND GENETIC ASPECTS OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION COMBINATION

BIOCHEMICAL AND GENETIC ASPECTS OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION COMBINATION

The content of endothelium-1 and C-type natriuretic peptide in the blood plasma in correlation with the gene polymorphism of endothelial nitric oxide synthase was studied in 35 patients with chronic obstructive pulmonary disease (COPD), 35 patients with arterial hypertension (AH) and in 40 patients...

Full description

Bibliographic Details
Main Authors:	O. S. Polunina, I. V. Sevostyanova, A. Kh. Akhmineeva, L. P. Voronina
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2014-02-01
Series:	Кубанский научный медицинский вестник
Subjects:	хроническая обструктивная болезнь легких артериальная гипертензия полиморфизм гена эндотелиальной синтазы оксида азота эндотелин-1 натрийуретический пептид типа с chronic obstructive pulmonary disease arterial hypertension gene polymorphism of endothelial nitric oxide synthase endothelium-1 c-type natriuretic peptide
Online Access:	https://ksma.elpub.ru/jour/article/view/37

Similar Items

CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: A. Kh. Akhmineeva, et al.
Published: (2014-02-01)

The level of c-type natriuretic peptide in patients with respiratory cardial comorbidity, depending on genotypes of the gene of endothelial nitric oxide synthase
by: O S Polunina, et al.
Published: (2013-12-01)

The influence of catalaza gene polymorphism on the development of cardiovascular pathology in chronic obstructive pulmonary disease
by: T A Uklistaya, et al.
Published: (2012-12-01)

Osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh
by: Dmitriy Aleksandrovich Napalkov, et al.
Published: (2013-09-01)

Circadian blood pressure profile in patients with arterial hypertension and chronic obstructive pulmonary disease
by: T. E. Steshina, et al.
Published: (2005-08-01)

Effektivnost' i bezopasnost' primeneniya Betaloka ZOK i Logimaksa u bol'nykh myagkoy arterial'noy gipertenziey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh
by: I E Chazova, et al.
Published: (2005-03-01)

CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN
by: N. A. Karoli, et al.
Published: (2015-09-01)

THE ROLE OF FRACTALKINE AS A MARKER OF THE INFLAMMATORY ACTIVITY AT COMBINED RESPIRATORY CARDIAC PATHOLOGY
by: A. Kh. Akhmineeva, et al.
Published: (2014-02-01)

THE EFFECT OF SOCIO-ECONOMIC FACTORS ON THE QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE IN CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-06-01)

FEATURES OF THE PSYCHOLOGICAL PROFILE OF PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE IN THE CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-07-01)

THE RELATIONSHIP BETWEEN THE LEVEL OF SUPEROXIDDISMUTASE AND THE COEFFICIENT OF ENDOTHELIAL FUNCTION AT RESPIRATORY-CARDIAC COMORBIDITY
by: O. S. Polunina, et al.
Published: (2014-02-01)

The chronic obcructive pulmonary disease in military veterans: problems and perspectives
by: G I Gurko
Published: (2010-12-01)

ANTHROPOMETRIC FEATURES AND COMPONENT STRUCTURE OF BODY MASS IN MEN WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-05-01)

Approaches to the diagnosis, treatment and prevention of exacerbations of chronic obstructive pulmonary disease. According to the materials of the Congress «Chelovek I lekarstvo» and the Summit of pulmonologists-2019
by: Yu. V. Evsyutina
Published: (2019-12-01)

Influence of COPD on the development of renal disease and identification of nature of kidney with specific markers
by: V V Trishina, et al.
Published: (2012-06-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

Role of copd in the development of kidney pathology
by: V V Trishina, et al.
Published: (2011-06-01)

Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity
by: A. Kh. Akhmineeva, et al.
Published: (2014-08-01)

FEATURES OF INDICATORS OF DAILY MONITORING OF ARTERIAL PRESSURE IN MEN WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CONTEXT OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-05-01)

Антибактериальная терапия инфекций дыхательных путей: практические рекомендации
Published: (2016-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

SYSTEMIC ARTERIAL HYPERTENSION ASSOCIATED WITH CHRONIC OBSTRUCTIVE LUNG DISEASE
by: S. A. Pavlishchuk, et al.
Published: (2014-02-01)

Кардиореспираторные послеоперационные осложнения у пациентов с ишемической болезнью сердца после планового коронарного шунтирования: связь с функцией легких
by: E. V. Bazdyrev, et al.
Published: (2017-07-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

Methodological aspects of the study of the pharmaceutical care to patients of chronic obstructive pulmonary disease
by: N O Karabintseva, et al.
Published: (2013-12-01)

ЗНАЧЕНИЕ N-КОНЦЕВОГО МОЗГОВОГО НАТРИЙУРЕТИЧЕСКОГО ПЕПТИДА У БОЛЬНЫХ ХРОНИЧЕСКОЙ РЕВМАТИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
by: O. V. Petrova, et al.
Published: (2015-10-01)

CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN: ROLE OF CHRONIC PULMONARY OBSTRUCTIVE DISEASE
by: N. T. Vatutin, et al.
Published: (2016-08-01)

Readmissions for chronic obstructive pulmonary disease in actual clinical practice
by: A F Yakupova, et al.
Published: (2018-04-01)

Pharmacoepidemiological treatment analysis of the chronic obstructive pulmonary disease and bronchial asthma at the inpatients department
by: I V Tarasenko, et al.
Published: (2010-12-01)

КЛИНИЧЕСКОЕ ПРИМЕНЕНИЕ КВАДРОПРИЛА У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ В СОЧЕТАНИИ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ
Published: (2006-12-01)

FEATURES OF THE SYNTHESIS OF NITRIC OXIDE IN PATIENTS WITH BRONCHIONAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Z. O. Dzuskaeva, et al.
Published: (2015-06-01)

Natriuretic peptide family. Options for use in outpatient practice
by: S. V. Ivanova, et al.
Published: (2014-12-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Magnetocardiography in the diagnosis of lesions fibrillation in patients with COPD and ACA
by: G G Ivanov, et al.
Published: (2015-12-01)

Automatic classification of patient groups using magnetocardiography in the diagnosis of the atria lesions in patients with chronic obstructive pulmonary disease and coronary heart disease
by: G G Ivanov, et al.
Published: (2015-12-01)

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
by: E. A. Shelest, et al.
Published: (2015-09-01)

Magnetocardiographic QRS complex in patients with paroxysmal atrial fibrillation and chronic obstructive pulmonary disease
by: G G Ivanov, et al.
Published: (2015-12-01)

Regional pharmacotherapy features of a bronchial asthma and chronic obstructive pulmonary disease
by: V A Lopukhova, et al.
Published: (2010-12-01)

Peculiarities of application of pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease
by: Yu. G. Krylova, et al.
Published: (2015-12-01)

Topical problems in the clinical application of -adrenoblockers
by: David Vasil'evich Nebieridze
Published: (2009-12-01)